Cargando…
Experimental and spontaneous metastasis assays can result in divergence in clonal architecture
Intratumoural heterogeneity is associated with poor outcomes in breast cancer. To understand how malignant clones survive and grow in metastatic niches, in vivo models using cell lines and patient-derived xenografts (PDX) have become the gold standard. Injections of cancer cells in orthotopic sites...
Autores principales: | Serrano, Antonin, Weber, Tom, Berthelet, Jean, El-Saafin, Farrah, Gadipally, Sreeja, Charafe-Jauffret, Emmanuelle, Ginestier, Christophe, Mariadason, John M., Oakes, Samantha R., Britt, Kara, Naik, Shalin H., Merino, Delphine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406815/ https://www.ncbi.nlm.nih.gov/pubmed/37550477 http://dx.doi.org/10.1038/s42003-023-05167-5 |
Ejemplares similares
-
Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin
por: Berthelet, Jean, et al.
Publicado: (2022) -
Breast cancer stem cells: tools and models to rely on
por: Charafe-Jauffret, Emmanuelle, et al.
Publicado: (2009) -
Targeting breast cancer stem cells: fishing season open!
por: Ginestier, Christophe, et al.
Publicado: (2010) -
p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012) -
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
por: Berthelet, Jean, et al.
Publicado: (2021)